Showing results (21-30 of 502) with videos related to
Sort By:
Pageof 51
Circulation|December 1, 1993
Circulating and tissue endothelin immunoreactivity in hypercholesterolemic pigsA Lerman, M W Webster, J H Chesebro, et al.Postgraduate Medicine|July 1, 1985
Platelet-inhibitor therapy in cardiovascular disease. Effective defense against thromboembolismJ H Chesebro, P M Steele, V FusterAnnual Review of Medicine|January 1, 1985
Intracardiac thrombi and systemic thromboembolism: detection, incidence, and treatmentJ H Chesebro, M Ezekowitz, L Badimon, et al.Journal of the American College of Cardiology|December 1, 1988
Antithrombotic therapy after myocardial reperfusion in acute myocardial infarctionV Fuster, B Stein, L Badimon, et al.Circulation|November 1, 1993
Recombinant hirudin in patients with chronic, stable coronary artery disease. Safety, half-life, and effect on coagulation parametersP Zoldhelyi, M W Webster, V Fuster, et al.Circulation|February 15, 1996
Does antithrombotic therapy influence residual thrombus after thrombolysis of platelet-rich thrombus? Effects of recombinant hirudin, heparin, or aspirinJ S Mruk, P Zoldhelyi, M W Webster, et al.Circulation|March 1, 1993
Coronary atherosclerosis. A multifactorial diseaseJ J Badimon, V Fuster, J H Chesebro, et al.Journal of the American College of Cardiology|February 1, 1993
Exogenous prostacyclin decreases vasoconstriction but not platelet thrombus deposition after arterial injuryJ Y Lam, J H Chesebro, L Badimon, et al.Current Problems in Cardiology|July 1, 1988
Antithrombotic therapy for patients with cardiac diseaseW J Penny, J H Chesebro, M Heras, et al.Journal of the American College of Cardiology|December 1, 1986
Thrombosis and embolism from cardiac chambers and infected valvesP C Adams, M Cohen, J H Chesebro, et al.Pageof 51